Atlas Trials

RSV Illness in ≤12 Months of Participants

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch RSV Illness in ≤12 Months of Participants

RecordFirmDate
A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness (NCT00421304)MedImmune LLC2007-01-10

Track RSV Illness in ≤12 Months of Participants automatically

Every clearance here is in the API, with alerts when new ones post.